Dr. HyunDae Cho appointed to NIH Special Emphasis Review Panels 21 October 20160CommentsCrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry,…Read More